CARRA Registry

Observational Study of Pediatric Rheumatic Disease

About the Study

Currently Recruiting: Participants

Study Drug/Intervention: Observational Registry

Study Timeline: This study is expected to conclude in December 2028.

Visit the Study Website ID: NCT02418442


Study Objectives

  1. Prospectively collect essential data from children, adolescents and young adults with pediatric onset rheumatic diseases.
  2. Evaluate the safety of therapeutic agents in persons with pediatric onset rheumatic diseases.

Participation Criteria

  1. Onset of rheumatic disease prior to age 16 years for juvenile idiopathic arthritis and onset prior to age 19 years for all other rheumatic diseases
  2. Subject and/or parent/legal guardian is able to provide written informed consent and willing to comply with study procedures
  3. Subject and/or parent/ legal guardian is willing to be contacted in the future by study staff


Childhood Arthritis and Rheumatology Research Alliance (CARRA)

Learn More